In this week's episode of the Gaining Health podcast, host Karli Burridge discusses the SELECT Trial and the results for implementation into obesity medicine practice.  The improvements in cardiovascular disease and obesity management through semaglutide (GLP-1 receptor agonist) medication treatment have now also been shown in patients without diabetes.  This landmark study is a step closer to victory for the obesity treatment community and patients struggling with obesity management.https://www.nejm.org/doi/full/10.1056/NEJMoa2307563Support the showThe Gaining Health Podcast will release a new episode monthly, every second or third Wednesday of the month. Episodes including interviews with obesity experts as well as scientific updates and new guidelines for the management of obesity.If you're a clinician or organization looking to start or optimize an obesity management program, and you want additional support and resources, check out the Gaining Health website! We offer a Roadmap to starting an obesity program or practice, pre-recorded Master Classes, digital resources including patient education materials and office forms, and much more! Check out our resources on our Gaining Health Shop! If you are loving this podcast, please consider supporting us on Patreon

Ver todos los episodios